Home
Henry Skinner, Ph.D.
CEO, AMR Action Fund
- Former Managing Director of Novartis Venture Fund; former SVP Venture at Tekla Capital Management
- Former CEO of SelectX Pharmaceuticals
- B.S./M.S. Biotechnology from Worcester Polytechnic; Ph.D. Microbiology from University of Illinois